Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 1/20 | 0.38 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.38 |
| ▸ | CTSK | P43235 | 2/20 | 0.37 |
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | ZDHHC20 | Q5W0Z9 | 2/20 | 0.34 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CTSL | P07711 | 1/20 | 0.32 |
| ▸ | CTSB | P07858 | 1/20 | 0.32 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.32 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.32 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17924972 | 0.89 | CTSK (0.39) | CTSKHCAR2ZDHHC20ZDHHC2MAPT | |
| SCHEMBL9624817 | 0.87 | HCAR2 (0.46) | PRKCAPRKCDCTSKHCAR2TSHR | |
| SCHEMBL952461 | 0.87 | HCAR2 (0.46) | PRKCAPRKCDCTSKHCAR2TSHR | |
| SCHEMBL2896246 | 0.87 | HCAR2 (0.46) | PRKCAPRKCDCTSKHCAR2TSHR | |
| SCHEMBL18831960 | 0.85 | HCAR2 (0.47) | PRKCAPRKCDCTSKHCAR2TSHR | |
| SCHEMBL2100907 | 0.85 | HCAR2 (0.47) | PRKCAPRKCDCTSKHCAR2TSHR | |
| SCHEMBL9147419 | 0.85 | HCAR2 (0.47) | PRKCAPRKCDCTSKHCAR2TSHR | |
| SCHEMBL10386208 | 0.85 | HCAR2 (0.47) | PRKCAPRKCDCTSKHCAR2TSHR | |
| SCHEMBL9153611 | 0.85 | HCAR2 (0.47) | PRKCAPRKCDCTSKHCAR2TSHR | |
| SCHEMBL2099261 | 0.85 | HCAR2 (0.47) | PRKCAPRKCDCTSKHCAR2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230138395-A1 | PHARMACEUTICAL COMPOSITIONS OF A THERAPEUTIC POLYENE MACROLIDE AND METHODS OF THEIR USE | BIOSERGEN AS (NO) | 2023-05-04 | — | — | US | claimed |
| EP-4110305-A1 | PHARMACEUTICAL COMPOSITIONS OF A THERAPEUTIC POLYENE MACROLIDE AND METHODS OF THEIR USE | Biosergen AS (NO) | 2023-01-04 | — | — | EP | claimed |
| EP-2747791-A1 | PROTECTIVE WOUND DRESSING DEVICE FOR ORAL AND PHARYNGEAL SPACE | Ethicon, Inc. (US) | 2014-07-02 | — | — | EP | claimed |
| WO-2013028672-A1 | PROTECTIVE WOUND DRESSING DEVICE FOR ORAL AND PHARYNGEAL SPACE | ETHICON, INC. (US) | 2013-02-28 | — | — | WO | claimed |
| EP-4717744-A1 | USE OF A COMPOSITION BASED ON CYANOACRYLATE AND (METH)ACRYLATE | Bostik SA (FR) | 2026-04-01 | — | — | EP | disclosed |
| US-20250339580-A1 | MEDICAL TISSUE ADHESIVE COMPOSITION | OKAPI MEDICAL LLC (US) | 2025-11-06 | — | — | US | disclosed |
| EP-4587530-A1 | CYANOACRYLATE COMPOSITIONS | Henkel AG & Co. KGaA (DE) | 2025-07-23 | — | — | EP | disclosed |
| US-20250215271-A1 | Cyanoacrylate compositions | HENKEL AG & CO KGAA (DE) | 2025-07-03 | — | — | US | disclosed |
| CN-119895001-A | Cyanoacrylate compositions | 汉高股份有限及两合公司 | 2025-04-25 | — | — | CN | disclosed |
| WO-2024056276-A1 | CYANOACRYLATE COMPOSITIONS | HENKEL AG & CO. KGAA (DE) | 2024-03-21 | — | — | WO | disclosed |
| EP-4259672-A1 | HIGH STRENGTH CYANOACRYLATE-BASED TAPES | Henkel AG & Co. KGaA (DE) | 2023-10-18 | — | — | EP | disclosed |
| US-20230312800-A1 | HIGH STRENGTH CYANOACRYLATE-BASED TAPES | HENKEL AG & CO KGAA (DE) | 2023-10-05 | — | — | US | disclosed |
| US-20060078523-A1 | Composition comprising at least one electrophilic monomer and at least one acid in a cosmetically acceptable anhydrous medium, and use thereof for cosmetic treatment of the hair | L'OREAL S.A. (FR) | 2006-04-13 | — | — | US | disclosed |
| US-20060073426-A1 | Method for simulating spot varnish on a surprint proof | EASTMAN KODAK COMPANY | 2006-04-06 | — | — | US | disclosed |
| EP-1112859-B1 | Donor element for laser-induced thermal transfer | EASTMAN KODAK CO (US) | 2004-05-19 | — | — | EP | disclosed |
| EP-1151872-A2 | Donor element for laser-induced image transfer | EASTMAN KODAK COMPANY (US) | 2001-11-07 | — | — | EP | disclosed |
| EP-1112859-A2 | Donor element for laser-induced thermal transfer | EASTMAN KODAK COMPANY (US) | 2001-07-04 | — | — | EP | disclosed |
| US-6190827-B1 | A LASER-INDUCED WHITE TRANSFER IMAGE. | EASTMAN KODAK COMPANY | 2001-02-20 | — | — | US | disclosed |
| US-6165671-A | Laser donor element | EASTMAN KODAK COMPANY (US) | 2000-12-26 | — | — | US | disclosed |
| US-5576144-A | SUPPORT WITH COLOR LAYER DISPERSED IN POLYMER BINDER | EASTMAN KODAK COMPANY (US) | 1996-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230138395-A1 | PHARMACEUTICAL COMPOSITIONS OF A THERAPEUTIC POLYENE MACROLIDE AND METHODS OF THEIR USE | CEL, LIPA, HDAC6 | PRKCA 1639/4885PRKCD 2194/4885CTSK 855/4885 |
| US-20060078523-A1 | Composition comprising at least one electrophilic monomer and at least one acid in a cosmetically acceptable anhydrous medium, and use thereof for cosmetic treatment of the hair | HOGA1, OAT, SUCLG1 | PRKCA 3118/4885PRKCD 3746/4885CTSK 3044/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.